126 related articles for article (PubMed ID: 8862714)
1. Remission of refractory gestational trophoblastic disease with high-dose paclitaxel.
Termrungruanglert W; Kudelka AP; Piamsomboon S; Verschraegen CF; Edwards CL; Lifshitz S; Mante RP; Kavanagh JJ
Anticancer Drugs; 1996 Jul; 7(5):503-6. PubMed ID: 8862714
[TBL] [Abstract][Full Text] [Related]
2. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
3. [A case of metastatic choriocarcinoma responding to combination chemotherapy with paclitaxel and carboplatin].
Shimamoto K; Inatomi S; Fujimoto H; Sumioki H
Gan To Kagaku Ryoho; 2010 May; 37(5):943-6. PubMed ID: 20495335
[TBL] [Abstract][Full Text] [Related]
4. Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature.
Piamsomboon S; Kudelka AP; Termrungruanglert W; Van Besien K; Edwards CL; Lifshitz S; Schomer DF; Champlin R; Mante RP; Kavanagh JJ; Verschraegen CF
Eur J Gynaecol Oncol; 1997; 18(6):453-6. PubMed ID: 9443008
[TBL] [Abstract][Full Text] [Related]
5. A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease.
Hartenbach EM; Saltzman AK; Carter JR; Twiggs LB
Gynecol Oncol; 1995 Jan; 56(1):105-8. PubMed ID: 7529741
[TBL] [Abstract][Full Text] [Related]
6. Response of choriocarcinoma to paclitaxel. Case report and review of resistance.
Gerson R; Serrano A; Del Carmen Bello M; Lazaro M; Kudelka AP; Kavanagh JJ
Eur J Gynaecol Oncol; 1997; 18(2):108-10. PubMed ID: 9105857
[TBL] [Abstract][Full Text] [Related]
7. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
8. Refractory Gestational Trophoblastic Neoplasia: A Novel Drug Combination With Paclitaxel and Carboplatin Produces Durable Complete Remission.
Rathod PS; Kundargi R; Pallavi VR; Vijay CR; Devi UK; Bafna UD
Int J Gynecol Cancer; 2015 Nov; 25(9):1737-41. PubMed ID: 26401644
[TBL] [Abstract][Full Text] [Related]
9. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Holden L
Br J Obstet Gynaecol; 1991 Jun; 98(6):550-7. PubMed ID: 1651757
[TBL] [Abstract][Full Text] [Related]
10. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of gestational trophoblastic disease at a single institute.
Alici S; Eralp Y; Saip P; Argon A; Basaran M; Topuz E; Aydiner A
Tohoku J Exp Med; 2002 Jun; 197(2):95-100. PubMed ID: 12233789
[TBL] [Abstract][Full Text] [Related]
12. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
Matsui H; Iitsuka Y; Seki K; Sekiya S
Gynecol Obstet Invest; 1998; 46(1):5-8. PubMed ID: 9692333
[TBL] [Abstract][Full Text] [Related]
13. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
Soto-Wright V; Goldstein DP; Bernstein MR; Berkowitz RS
Gynecol Oncol; 1997 Jan; 64(1):156-9. PubMed ID: 8995566
[TBL] [Abstract][Full Text] [Related]
14. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
[TBL] [Abstract][Full Text] [Related]
15. [Methotrexate in gynecologic oncology].
Isonishi S; Terashima Y
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1896-900. PubMed ID: 8978793
[TBL] [Abstract][Full Text] [Related]
16. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
17. Actinomycin D as the primary agent for gestational trophoblastic disease.
Osathanondh R; Goldstein DP; Pastorfide GB
Cancer; 1975 Sep; 36(3):863-6. PubMed ID: 171055
[TBL] [Abstract][Full Text] [Related]
18. Regression pattern of beta human chorionic gonadotrophin in blood after chemotherapy for gestational trophoblastic neoplasia.
Burrows A; Faddy MJ; Khoo SK
Aust N Z J Obstet Gynaecol; 1996 Aug; 36(3):331-4. PubMed ID: 8883763
[TBL] [Abstract][Full Text] [Related]
19. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
20. Treatment of nonmetastatic gestational trophoblastic disease with sequential intramuscular and oral methotrexate.
Barter JF; Soong SJ; Hatch KD; Orr JW; Partridge EC; Austin JM; Shingleton HM
Gynecol Oncol; 1989 Apr; 33(1):82-4. PubMed ID: 2467846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
